A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program

(2022) Joseph P. Jarvis et al.   Journal of Personalized Medicine

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries

(2022) Kathrin Blagec et al.   PLoS One

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention

(2020) Naveen L. Pereira et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Development of the PG x‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐emptive Pharmacogenetic Testing

(2019) Cathelijne H. van der Wouden et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts

(2019) Katja S. Just et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care

(2019) Paul C. D. Bank et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI

(2019) Daniel M.F. Claassens et al.   NEW ENGLAND JOURNAL OF MEDICINE

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

(2018) Linda M Henricks et al.   LANCET ONCOLOGY

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

(2017) Katja Susanne Just et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now

(2017) Kristin W. Weitzel et al.   PHARMACEUTICAL RESEARCH

Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial

(2017) Lindsay S. Elliott et al.   PLoS One

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available

(2016) Matthias Samwald et al.   PLoS One

Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers

(2015) Henry M. Dunnenberger et al.   Annual Review of Pharmacology and Toxicology

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

(2015) Marieke J.H. Coenen et al.   GASTROENTEROLOGY

The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy

(2015) D. Brixner et al.   JOURNAL OF MEDICAL ECONOMICS

A Randomized Trial of Genotype-Guided Dosing of Warfarin

(2013) Munir Pirmohamed et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool

(2011) Ruairi M. Gallagher et al.   PLoS One

Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items

(2009) Ron D. Hays et al.   QUALITY OF LIFE RESEARCH

HLA-B*5701 Screening for Hypersensitivity to Abacavir

(2008) Simon Mallal et al.   NEW ENGLAND JOURNAL OF MEDICINE